Search - tctmd.com

Displaying 501 - 520 of 679

Sort: Relevancy | Date

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

Shelley Wood

August 01, 2018

News Conference News SCCT 2018

Research Priorities for Cardiac CT: Patient Selection, Test Integration, and Hard Outcomes

Yael L. Maxwell

July 26, 2018

News Conference News SCCT 2018

How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED?

Yael L. Maxwell

July 24, 2018

News Conference News SCCT 2018

Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD

Yael L. Maxwell

July 19, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

News Conference News SCCT 2018

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Yael L. Maxwell

July 16, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Daily News

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Caitlin E. Cox

June 25, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

Advertisement

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

TCTMD’s Top 10 Most Popular Stories for July 2018

Research Priorities for Cardiac CT: Patient Selection, Test Integration, and Hard Outcomes

How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED?

Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Once Again, ISCHEMIA Trial Feels the Squeeze

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content